Aging Clinical Trial
Official title:
Evaluation of a Probiotic on Psychological and Cognitive Effects in Middle and Older Adults
Verified date | February 2020 |
Source | Kent State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will determine whether supplementation of probiotic Lactobacillus Rhamnosus GG improves psychological status in middle age and older adults through a 12-week, randomized, double-blind, placebo-controlled clinical trial. Secondary analyses will be conducted to examine the possible benefits of probiotic supplementation on cognitive function and markers of physical health.
Status | Completed |
Enrollment | 200 |
Est. completion date | July 1, 2019 |
Est. primary completion date | January 1, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 55 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Age 55-75 years - Able to speak and read English Exclusion Criteria: - History of neurological, developmental, or severe psychiatric disorder (e.g. dementia, stroke, schizophrenia); - Antibiotic use in the past 30 days; - History of significant stomach or GI surgery (e.g. gastric bypass, cholecystectomy); - History of alcohol or illicit drug dependence; - History of severe heart, kidney, or liver problems (e.g. heart failure, liver failure); - Regular use of an acid-blocking medication in the past 30 days (i.e. proton pump inhibitor, H2 blocker); - Likely immunosuppression (e.g. chemotherapy treatment); - Regular use of other pre- or probiotic supplements in the past 30 days; - Severe gastrointestinal conditions including celiac disease, Crohn's disease, or diverticulitis. |
Country | Name | City | State |
---|---|---|---|
United States | Kent State Uniersity | Kent | Ohio |
Lead Sponsor | Collaborator |
---|---|
Kent State University | iHealth |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in score on Center for Epidemiologic Studies Depression - R (CES-D-R) | Depressive symptoms | Baseline and 12 week follow up | |
Primary | Change in score on State-Trait Anxiety Inventory | Anxiety symptoms | Baseline and 12 week follow up | |
Primary | Change in score on Perceived Stress Scale | Subjective stress | Baseline and 12 week follow up | |
Primary | Change in score on Positive and Negative Affect Schedule | Fluctuations in affect | Baseline and 12 week follow up | |
Primary | Change in score on Profile of Mood States | Fluctuations in affect - acute | Baseline and 12 week follow up | |
Primary | Change in score on Warwick-Edinburgh Mental Well-Being Scale | Subjective wellbeing | Baseline and 12 week follow up | |
Primary | Change in score on OECD Life Satisfaction scale (short) | Subjective wellbeing - general | Baseline and 12 week follow up | |
Primary | Change in score on Response to Stressful Events Scale | Emotion regulation | Baseline and 12 week follow up | |
Primary | Change in score on Connor-Davidson Resilience Scale | Emotional resilience | Baseline and 12 week follow up | |
Secondary | Change in Picture Sequence Memory Test and Auditory Verbal Learning Test scores | Memory | Baseline and 12 week follow up | |
Secondary | Change in Dimension Card Sort Test, Flanker Inhibitory Control, and List Sorting Working Memory Test scores | Executive function/Attention | Baseline and 12 week follow up | |
Secondary | Change in Pattern Comparison Processing Speed Test scores | Processing Speed | Baseline and 12 week follow up | |
Secondary | Change in SF-36 scores | Quality of Life | Baseline and 12 week follow up | |
Secondary | Change in Pittsburgh Sleep Quality Index scores | Sleep patterns | Baseline and 12 week follow up | |
Secondary | Change in Gastrointestinal Symptom Rating Scale scores | Subjective gastrointestinal symptoms | Baseline and 12 week follow up | |
Secondary | Change in HbA1c and fasting glucose values | Laboratory measures of glycemic control | Baseline and 12 week follow up | |
Secondary | Change in C-reactive protein, Interleukin-6, and TNF-alpha values | Laboratory measures of inflammation | Baseline and 12 week follow up | |
Secondary | Change in Total Cholesterol, HDL, LDL, and VLDL values | Laboratory meausres of lipid levels | Baseline and 12 week follow up | |
Secondary | Change in waking cortisol levels | Laboratory measure of cortisol | Baseline and 12 week follow up | |
Secondary | Change in composition of the gut microbiome | Laboratory measure of gut microbiome | Baseline and 12 week follow up | |
Secondary | Change in oral microbiome composition | Laboratory measure of oral microbiome | Baseline and 12 week follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |